NVCR logo

NovoCure Limited (NVCR) Cash from operations

annual CFO:

-$26.37M+$46.97M(+64.04%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NVCR annual cash flow from operations is -$26.37 million, with the most recent change of +$46.97 million (+64.04%) on December 31, 2024.
  • During the last 3 years, NVCR annual CFO has fallen by -$109.13 million (-131.86%).
  • NVCR annual CFO is now -126.60% below its all-time high of $99.15 million, reached on December 31, 2020.

Performance

NVCR Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

quarterly CFO:

-$35.66M-$32.21M(-933.47%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVCR quarterly cash flow from operations is -$35.66 million, with the most recent change of -$32.21 million (-933.47%) on March 31, 2025.
  • Over the past year, NVCR quarterly CFO has dropped by -$4.09 million (-12.96%).
  • NVCR quarterly CFO is now -166.69% below its all-time high of $53.48 million, reached on December 31, 2020.

Performance

NVCR quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

TTM CFO:

-$30.46M-$4.09M(-15.51%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NVCR TTM cash flow from operations is -$30.46 million, with the most recent change of -$4.09 million (-15.51%) on March 31, 2025.
  • Over the past year, NVCR TTM CFO has increased by +$57.72 million (+65.46%).
  • NVCR TTM CFO is now -123.72% below its all-time high of $128.40 million, reached on June 30, 2021.

Performance

NVCR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVCRcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NVCR Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+64.0%-13.0%+65.5%
3 y3 years-131.9%-867.3%-149.7%
5 y5 years-199.1%-1922.4%-192.6%

NVCR Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-131.9%+64.0%-259.1%at low-149.7%+65.5%
5 y5-year-126.6%+64.0%-166.7%at low-123.7%+65.5%
alltimeall time-126.6%+75.5%-166.7%at low-123.7%+74.6%

NVCR Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$35.66M(+933.5%)
-$30.46M(+15.5%)
Dec 2024
-$26.37M(-64.0%)
-$3.45M(-133.3%)
-$26.37M(-29.6%)
Sep 2024
-
$10.38M(-703.3%)
-$37.48M(-44.2%)
Jun 2024
-
-$1.72M(-94.6%)
-$67.17M(-23.8%)
Mar 2024
-
-$31.57M(+116.9%)
-$88.18M(+20.2%)
Dec 2023
-$73.34M(-338.2%)
-$14.56M(-24.6%)
-$73.34M(+17.4%)
Sep 2023
-
-$19.31M(-15.1%)
-$62.48M(+201.1%)
Jun 2023
-
-$22.74M(+35.9%)
-$20.75M(-216.9%)
Mar 2023
-
-$16.73M(+351.2%)
$17.75M(-42.4%)
Dec 2022
$30.79M(-62.8%)
-$3.71M(-116.5%)
$30.79M(-37.0%)
Sep 2022
-
$22.42M(+42.2%)
$48.90M(-3.9%)
Jun 2022
-
$15.76M(-527.5%)
$50.88M(-17.0%)
Mar 2022
-
-$3.69M(-125.6%)
$61.29M(-25.9%)
Dec 2021
$82.76M(-16.5%)
$14.40M(-41.0%)
$82.76M(-32.1%)
Sep 2021
-
$24.40M(-6.8%)
$121.83M(-5.1%)
Jun 2021
-
$26.17M(+47.2%)
$128.40M(+11.7%)
Mar 2021
-
$17.78M(-66.8%)
$114.97M(+16.0%)
Dec 2020
$99.15M(+272.5%)
$53.48M(+72.7%)
$99.15M(+88.4%)
Sep 2020
-
$30.97M(+143.1%)
$52.63M(+43.9%)
Jun 2020
-
$12.74M(+551.0%)
$36.57M(+11.2%)
Mar 2020
-
$1.96M(-71.9%)
$32.89M(+23.6%)
DateAnnualQuarterlyTTM
Dec 2019
$26.62M(-1527.3%)
$6.96M(-53.3%)
$26.62M(-27.0%)
Sep 2019
-
$14.91M(+64.4%)
$36.47M(+34.1%)
Jun 2019
-
$9.07M(-310.1%)
$27.20M(+155.6%)
Mar 2019
-
-$4.32M(-125.7%)
$10.64M(-670.7%)
Dec 2018
-$1.86M(-94.4%)
$16.81M(+198.2%)
-$1.86M(-91.4%)
Sep 2018
-
$5.64M(-175.2%)
-$21.58M(-12.5%)
Jun 2018
-
-$7.49M(-55.5%)
-$24.67M(+7.0%)
Mar 2018
-
-$16.82M(+480.5%)
-$23.05M(-30.4%)
Dec 2017
-$33.13M(-69.2%)
-$2.90M(-213.7%)
-$33.13M(-24.6%)
Sep 2017
-
$2.55M(-143.4%)
-$43.96M(-45.1%)
Jun 2017
-
-$5.88M(-78.2%)
-$80.00M(-22.7%)
Mar 2017
-
-$26.91M(+96.1%)
-$103.52M(-3.8%)
Dec 2016
-$107.59M(+7.7%)
-$13.72M(-59.0%)
-$107.59M(-10.3%)
Sep 2016
-
-$33.50M(+14.0%)
-$119.99M(+10.5%)
Jun 2016
-
-$29.39M(-5.1%)
-$108.60M(+6.1%)
Mar 2016
-
-$30.98M(+18.6%)
-$102.39M(+2.5%)
Dec 2015
-$99.88M(+34.5%)
-$26.12M(+18.2%)
-$99.88M(+35.4%)
Sep 2015
-
-$22.11M(-4.7%)
-$73.76M(+42.8%)
Jun 2015
-
-$23.19M(-18.5%)
-$51.66M(+81.5%)
Mar 2015
-
-$28.47M
-$28.47M
Dec 2014
-$74.24M(+40.8%)
-
-
Dec 2013
-$52.72M
-
-

FAQ

  • What is NovoCure Limited annual cash flow from operations?
  • What is the all time high annual CFO for NovoCure Limited?
  • What is NovoCure Limited annual CFO year-on-year change?
  • What is NovoCure Limited quarterly cash flow from operations?
  • What is the all time high quarterly CFO for NovoCure Limited?
  • What is NovoCure Limited quarterly CFO year-on-year change?
  • What is NovoCure Limited TTM cash flow from operations?
  • What is the all time high TTM CFO for NovoCure Limited?
  • What is NovoCure Limited TTM CFO year-on-year change?

What is NovoCure Limited annual cash flow from operations?

The current annual CFO of NVCR is -$26.37M

What is the all time high annual CFO for NovoCure Limited?

NovoCure Limited all-time high annual cash flow from operations is $99.15M

What is NovoCure Limited annual CFO year-on-year change?

Over the past year, NVCR annual cash flow from operations has changed by +$46.97M (+64.04%)

What is NovoCure Limited quarterly cash flow from operations?

The current quarterly CFO of NVCR is -$35.66M

What is the all time high quarterly CFO for NovoCure Limited?

NovoCure Limited all-time high quarterly cash flow from operations is $53.48M

What is NovoCure Limited quarterly CFO year-on-year change?

Over the past year, NVCR quarterly cash flow from operations has changed by -$4.09M (-12.96%)

What is NovoCure Limited TTM cash flow from operations?

The current TTM CFO of NVCR is -$30.46M

What is the all time high TTM CFO for NovoCure Limited?

NovoCure Limited all-time high TTM cash flow from operations is $128.40M

What is NovoCure Limited TTM CFO year-on-year change?

Over the past year, NVCR TTM cash flow from operations has changed by +$57.72M (+65.46%)
On this page